Georges Gebrael

News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
September, 2024
September 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  

Georges Gebrael
Jul 24, 2024, 13:22 | Insight
Neeraj Agarwal: Unacceptably low rates of NGS testing in metastatic Prostate Cancer
Neeraj Agarwal shared a post on X about a recent paper by Chadi Hage Chehade…
Jul 21, 2024, 20:01 | Blog
Assessing bone pain and survival in SWOG Cancer Research Network 1216 TAK700 in hormone sensitive prostate cancer
Sumanta K.Pal shared a post on X about a recent paper by Georges Gebrael et al.,…
Jul 21, 2024, 10:58 | Blog
Chadi Hage Chehade: NGS testing rates in patients with metastatic prostate and urothelial cancers
Petros Grivas shared a post by Chadi Hage Chehade, Post-Doctoral Research Fellow at Huntsman Cancer Institute, on X:…
Jul 14, 2024, 06:27 | Blog
Georges Gebrael: Baseline bone pain associated with lower survival in mHSPC
Georges Gebrael, Research Fellow at Huntsman Cancer Institute and University of Utah, shared on X/Twitter:…
Jul 12, 2024, 16:05 | Insight
Piotr Wysocki: Bone Pain and Survival Among Patients With mHSPC
Piotr Wysocki recently posted on LinkedIn: "Bone pain is linked to worse overall survival (OS) in…
Jul 1, 2024, 12:00 | Blog
Shilpa Gupta: Congrats Neeraj Agarwal on another stellar achievement
Shilpa Gupta shared on X/Twitter: "Congrats Neeraj Agarwal on yet another stellar achievement! And for…
May 2, 2024, 08:36 | Insight
Chadi Hage Chehade: Happy to share our editorial recently published in Cancer Cell!
Chadi Hage Chehade, Post-Doctoral Research Fellow at Huntsman Cancer Institute, shared a post by Neeraj Agarwal…
Apr 7, 2024, 11:45 | Drugs
Yüksel Ürün: Adding immunotherapy to cabozantinib for mccRCC after 1st line immunotherapy showed no extra benefit in real-world data
Yüksel Ürün, Doctorate Professor at the Faculty of Medicine, Ankara University, Turkey, shared a post…
Apr 4, 2024, 20:02 | Drugs
Georges Gebrael: RWD of Cabozantinib and ICI vs. cabozantinib monotherapy align with CONTACT03 trial results
Georges Gebrael, Research Fellow at Huntsman Cancer Institute and University of Utah, shared on X/Twitter:…
Apr 4, 2024, 14:05 | Insight
Toni Choueiri: More evidence that ICI after ICI may not be effective
Toni Choueiri, Professor of Medicine at Harvard Medical School and Director of the Lank Center…
Apr 4, 2024, 13:47 | Insight
Sumanta K. Pal: Excellent real world confirmation of our observations in CONTACT03
Sumanta K. Pal, Professor and Vice Chair of Academic Affairs at City of Hope, shared…
Mar 19, 2024, 20:38 | Insight
Georges Gebrael: Exploratory analysis of TITAN by Soumyajit Roy, Daniel E Spratt
Quoting Georges Gebrael, Research Fellow at Huntsman Cancer Institute and University of Utah, on X/Twitter:…
Oct 1, 2023, 20:03 | Career
Sumanta K. Pal: I have had the distinct pleasure of working directly with Georges Gebrael.
Sumanta K. Pal, Co-director of City of Hope's Kidney Cancer Program and  head of the…
All: 13 Posts: 1 - 100
Special Coverage